Rebecca Charow
Princess Margaret Cancer Centre
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rebecca Charow.
Journal of Oncology Practice | 2015
Chongya Niu; Lawson Eng; Xin Qiu; Xiaowei Shen; Osvaldo Espin-Garcia; Yuyao Song; Dan Pringle; Mary Mahler; Oleksandr Halytskyy; Rebecca Charow; Christine Lam; Ravi M. Shani; Jodie Villeneuve; Kyoko Tiessen; M Catherine Brown; Peter Selby; Doris Howell; Jennifer M. Jones; Wei Xu; Geoffrey Liu; Shabbir M.H. Alibhai
PURPOSE Improved cancer screening and treatment have led to a greater focus on cancer survivorship care. Older cancer survivors may be a unique population. We evaluated whether older cancer survivors (age ≥ 65 years) had lifestyle behaviors, attitudes, and knowledge distinct from younger survivors. PATIENTS AND METHODS Adult cancer survivors with diverse cancer subtypes were recruited from Princess Margaret Cancer Centre (Toronto, Ontario, Canada). Multivariable models evaluated the effect of age on smoking, alcohol, and physical activity habits, attitudes toward and knowledge of these habits on cancer outcomes, and lifestyle information and recommendations received from health care providers, adjusted for sociodemographic and clinicopathologic covariates. RESULTS Among the 616 survivors recruited, 23% (n = 139) were older. Median follow-up since diagnosis was 24 months. Older survivors were more likely ex-smokers and less likely current smokers than younger survivors, but they were less likely to know that smoking could affect cancer treatment (adjusted odds ratio [OR], 0.53; P = .007) or prognosis (adjusted OR, 0.53; P = .008). Older survivors were more likely to perceive alcohol as improving overall survival (adjusted OR, 2.39; P = .02). Rates of meeting moderate-to-vigorous physical activity guidelines 1 year before diagnosis (adjusted OR, 0.55; P = .02) and maintaining and improving their exercise levels to meet these guidelines after diagnosis (adjusted OR, 0.48; P = .02) were lower in older survivors. Older and younger cancer survivors reported similar rates of receiving lifestyle behavior information from health care providers (P = .36 to .98). CONCLUSION Older cancer survivors reported being less aware of the impact of smoking on their overall health, more likely perceived alcohol as beneficial to survival, and were less likely to meet exercise goals compared with younger survivors. Survivorship programs need to consider age when counseling on lifestyle behaviors.
Current Oncology | 2016
Hiten Naik; Xin Qiu; M. C. Brown; Lawson Eng; Dan Pringle; Mary Mahler; Henrique Hon; Kyoko Tiessen; Henry Thai; Valerie Ho; Christina Gonos; Rebecca Charow; Vivien Pat; Margaret Irwin; Lindsay Herzog; Anthea Ho; Wei Xu; Jennifer M. Jones; Doris Howell; Geoffrey Liu
PURPOSE Smoking cessation and increased physical activity (pa) have been linked to better outcomes in cancer survivors. We assessed whether socioeconomic factors influence changes in those behaviours after a cancer diagnosis. METHODS As part of a cross-sectional study, a diverse group of cancer survivors at the Princess Margaret Cancer Centre (Toronto, ON), completed a questionnaire about past and current lifestyle behaviours and perceptions about the importance of those behaviours with respect to their health. The influence of socioeconomic indicators on smoking status and physical inactivity at 1 year before and after diagnosis were assessed using multivariable logistic regression with adjustment for clinico-demographic factors. RESULTS Of 1222 participants, 1192 completed the smoking component. Of those respondents, 15% smoked before diagnosis, and 43% of those smokers continued to smoke after. The proportion of survivors who continued to smoke increased with lower education level (p = 0.03). Of the 1106 participants answering pa questions, 39% reported being physically inactive before diagnosis, of whom 82% remained inactive afterward. Survivors with a lower education level were most likely to remain inactive after diagnosis (p = 0.003). Lower education level, household income, and occupation were associated with the perception that pa had no effect or could worsen fatigue and quality of life (p ≤ 0.0001). CONCLUSIONS In cancer survivors, education level was a major modifier of smoking and pa behaviours. Lower socioeconomic status was associated with incorrect perceptions about pa. Targeting at-risk survivors by education level should be evaluated as a strategy in cancer survivorship programs.
The Canadian journal of clinical pharmacology | 2016
Hiten Naik; Xin Qiu; M Catherine Brown; Mary Mahler; Henrique Hon; Kyoko Tiessen; Henry Thai; Valerie Ho; Christina Gonos; Rebecca Charow; Vivien Pat; Margaret Irwin; Lindsay Herzog; Anthea Ho; Wei Xu; Doris Howell; Soo Jin Seung; Geoffrey Liu; Nicole Mittmann
Evidence from literature illustrates that from a pathophysiological perspective, sulfonylureas (SU) may impact the heart three ways: directly by intrinsic properties from a pharmacological receptor perspective, indirectly by adverse effects related to hypoglycemia, and obesity. From a pharmacologlogical receptor perspective, SU can bind to ATP-sensitive potassium channels in cardiomyocytes. Channel binding by SU in cardiac tissue may prevent ischemia myocardial protective mechanisms. From a pathophysiological perspective, obesity is associated with cardiac issues such as pulmonary hypertension, left ventricular hypertrophy, arrhythmia, and atrial fibrillation. From a pathophysiological perspective, hypoglycemia is associated with cardiac sympathetic activation and QT prolongation. With the high prevalence and incidence of diabetes, obesity and aging, future basic and clinical studies should further explore the questions related to the pathophysiology of SU utilization and potential cardiac impact in randomized clinical trials and real-world outcome research settings.Chronic obstructive pulmonary disease (COPD) is a chronic progressive respiratory disease with partially reversible airway obstruction and lung hyperventilation progressing to increasingly frequent and severe exacerbations. The condition is mainly caused by smoking but may result from other causes such as environmental exposure or occupational hazards. Based on Statistics Canada survey data the prevalence of COPD is approximately 4% of the general population, or about 780,000 adults in Canada with 28,000 in Manitoba.
Journal of Clinical Oncology | 2012
Petra Martin; Catherine Brown; Sinead Cuffe; Dan Pringle; Mary Mahler; Jodie Villeneuve; Chongya Niu; Rebecca Charow; Christine Lam; Ravi M. Shani; Henrique Hon; Memori Otsuka; Osvaldo Epsin-Garcia; Wei Xu; Shabbir Alibbhai; Jodie Jenkinson; Geoffrey Liu
319 Background: PGT in oncology can be used to predict the efficacy and toxicity of a particular treatment in an individual. Previous work by our group has demonstrated that among cancer patients willing to undergo chemotherapy, >98% wanted PGT testing if it could identify patients who would respond to chemo. However, in the original study using a paper questionnaire, 22% of patients did not understand the concept of PGT and its clinical implications. Therefore, we have devised a simpler, more visual questionnaire in electronic format using iPad technology and simple animations. We are assessing if patient understanding using this format is increased and also if patients prefer completing the survey with this novel technology. METHODS An interim analysis of a broad cross-section of cancer patients using an iPad was performed. PGT questions related to hypothetical efficacy, toxicity, time to test results, willingness to pay as well as understanding of PGT scenarios were assessed. RESULTS 135 cancer patients (87% adjuvant, 12% metastatic; 27% breast, 25% colon, 22% heme malignancy, 23% other) attending Princess Margaret Hosptial participated. 85% of patients accepted chemo that had a 5% absolute improvement in survival and <10% chance of side effects. 94% of patients chose to have PGT if it could identify subsets of patients who would benefit from chemo. The median that patients were willing to pay for PGT was
Cancer Prevention Research | 2015
Lawson Eng; Xin Qiu; Jie Su; M Catherine Brown; Margaret Irwin; Dan Pringle; Hiten Naik; Chongya Niu; Mary Mahler; Henrique Hon; Kyoko Tiessen; Rebecca Charow; Henry Thai; Valerie Ho; Vivien Pat; Lindsay Herzog; Anthea Ho; Jennifer M. Jones; Doris Howell; David P. Goldstein; Meredith Giuliani; Wei Xu; Peter Selby; Geoffrey Liu
250 (range
Journal of Clinical Oncology | 2014
Hiten Naik; Geoffrey Liu; Xin Qiu; Dan Pringle; Catherine Brown; Lawson Eng; Mary Mahler; Henrique Hon; Kyoko Tiessen; Henry Thai; Valerie Ho; Christina Gonos; Rebecca Charow; Vivien Pat; Margaret Irwin; Lindsay Herzog; Anthea Ho; Jennifer M. Jones; Wei Xu; Doris Howell
0-
Journal of Clinical Oncology | 2013
Donna M. Graham; Osvaldo Espin-Garcia; Catherine Brown; Oleksandr Halytskyy; Mary Mahler; Dan Pringle; Lawson Eng; Chongya Niu; Christine Lam; Rebecca Charow; Jodie Villeneuve; Ravi M. Shani; Kyoko Tiessen; Doris Howell; Jennifer M. Jones; Shabbir M.H. Alibhai; Wei Xu; Geoffrey Liu
5,000), however the median that patients felt was a reasonable price was
Journal of Clinical Oncology | 2012
Lawson Eng; Dan Pringle; Catherine Brown; Xiaowei Shen; Mary Mahler; Chongya Niu; Jodie Villeneuve; Rebecca Charow; Christine Lam; Ravi M. Shani; Shabbir M.H. Alibhai; Jennifer M. Jones; Wei Xu; Geoffrey Liu; Samir C. Grover
100 (
Neuro-Oncology Practice | 2018
Janet Papadakos; Arnav Agarwal; Rebecca Charow; Naa Kwarley Quartey; Anna D’souza; Meredith Giuliani; Barbara-Ann Millar; Christine Massey; D.B. Shultz; Caroline Chung
0-
Journal of Clinical Oncology | 2017
Lawson Eng; Dan Pringle; Xin Qiu; Xiaowei Shen; Chongya Niu; Mary Mahler; Oleksandr Halytskyy; Rebecca Charow; Christine Lam; Ravi M. Shani; Jodie Villeneuve; Kyoko Tiessen; M Catherine Brown; Shabbir M.H. Alibhai; Jennifer M. Jones; Doris Howell; David P. Goldstein; Wei Xu; Peter Selby; Geoffrey Liu
5,000). 11% of patients admitted that they did not understand the concept of PGT and its clinical implications. CONCLUSIONS Almost all patients who were willing to undergo chemo were also willing to accept PGT. Fewer patients in this study compared with our original paper directed questionnaire described themselves as lacking an understanding of PGT (11% versus 22% respectively), suggesting that survey administration on an iPad with a visual characterization of question scenarios improved understanding. Final data from over 300 patients will be analyzed in the fall, which would include data on patient attitudes on use of such technology for communication and decision making.